What is confidential?
What is confidential? And what should you disclose before and after a CDA is signed?
What is confidential? And what should you disclose before and after a CDA is signed?
Want to meet more prospective clients and investors at #BIO2020? Lacerta BIO is offering you the opportunity to sponsor your own event in San Diego.
Is Japan being ignored as a licensing partner in the biotech industry? Is China now getting all of the attention? Lacerta Bio explores this question.
https://www.economist.com/graphic-detail/2019/05/22/republicans-are-struggling-to-fix-americas-dysfunctional-health-care-system Undoubtably many of you have seen this graphic as it has made the rounds. Indeed, there are reasons to be concerned. Flat to declining life expectancy in a country…
What is Digital Scouting? The term “digital scouting” refers to an increasingly popular approach taken by multinational pharmaceutical companies to source and evaluate in-licensing opportunities.As the name implies, it…
Derek Lowe is a medicinal chemist with ~30-years of industry experience, mainly in Big Pharma. His very popular In The Pipeline blog is a must read for anyone who wants…
Last year was unquestionably an excellent year from an FDA NCE approval perspective. A recent article in Nature Reviews Drug Discovery has the full list. An interactive table (complete with…
That didn't take long. In mid-December, we released a short video that summarized a few items of interest from 2018. We also offered a few predictions for 2019. One of…
Somewhere in the deep recesses of our collective memory, the Concentration Ratio resides. It's a quick measure of how competitive an industry is. You can read all about it here. …
Good stuff... BIO recently published their latest report characterizing innovation in highly prevalent, chronic diseases. A full list of past reports is available here. They are short, data-rich, and quite…